Amundi MSCI World Small Cap ESG Broad Transition UCITS ETF Accum USD (GB:WMSC) Price & Chart

Stifel lowered the firm’s price target on Watts Water (WTS) to $430 from $445 and keeps a Buy rating on the shares. Published first on TheFly – the ultimate source

Goldman Sachs analyst Salveen Richter raised the firm’s price target on Moderna (MRNA) to $195 from $137 and keeps a Neutral rating on the shares. Moderna delivered a significant Q3

Citi lowered the firm’s price target on Federal Realty (FRT) to $121 from $130 and keeps a Neutral rating on the shares. Published first on TheFly – the ultimate source

BofA lowered the firm’s price target on Federal Realty (FRT) to $130 from $136 and keeps a Buy rating on the shares. The firm updated models for Q3 results among

Moderna (MRNA) has disclosed a new risk, in the Share Price & Shareholder Rights category. Moderna faces potential dilution risk for existing stockholders if its convertible notes are exchanged for

Royal Gold (($RGLD)) has held its Q3 earnings call. Read on for the main highlights of the call. Royal Gold delivered a strongly positive quarter, marked by records in revenue,

BofA raised the firm’s price target on Moderna (MRNA) to $260 from $220 and keeps a Neutral rating on the shares after what the firm calls a “clean beat and

RBC Capital raised the firm’s price target on Moderna (MRNA) to $145 from $130 and keeps a Sector Perform rating on the shares. Published first on TheFly – the ultimate

TD Cowen analyst Tyler Van Buren raised the firm’s price target on Moderna (MRNA) to $110 from $90 and keeps a Hold rating on the shares. “Strong” and balanced U.S.